Characterization of a novel series of potent, selective inhibitors of wild type and mutant/fusion anaplastic lymphoma kinase

被引：6

作者：

Wilcoxen, Keith M. ^{[1
]}

Brake, Rachael L. ^{[2
]}

Saffran, Doug ^{[2
]}

Teffera, Yohannes ^{[2
]}

Choguette, Deborah ^{[2
]}

Whittington, Doug ^{[2
]}

Yu, Violeta ^{[2
]}

Romero, Karina ^{[2
]}

Bode, Christiane ^{[2
]}

Stellwagen, John ^{[2
]}

Potashman, Michelle ^{[2
]}

Emkey, Renee ^{[2
]}

Andrews, Paul ^{[2
]}

Drew, Allison E. ^{[2
]}

Xu, Man ^{[2
]}

Szilvassy, Stephen ^{[3
]}

Al-Assad, Samer ^{[3
]}

Lewis, Richard T. ^{[2
]}

机构：

[1] Tesaro Inc, Waltham, MA USA

[2] Amgen Inc, Cambridge, MA USA

[3] Amgen Inc, Thousand Oaks, CA USA

来源：

CANCER RESEARCH | 2012年 / 72卷

关键词：

D O I：

10.1158/1538-7445.AM2012-1795

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1795

引用

页数：2

共 50 条

[1] Characterization of novel potent and selective anaplastic lymphoma kinase (ALK) inhibitors
Lovly, C. M.
de Stanchina, E.
Chen, H.
Liang, C.
Pao, W.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[2] Structural and kinetic characterization of crizotinib with wild-type and mutant anaplastic lymphoma kinase
McTigue, Michele A.
Timofeevski, Sergei L.
Liu, Wei
Deng, Ya-Li
Marrone, Tami
Cui, Jean
Brooun, Alexei
CANCER RESEARCH, 2011, 71
[3] Design and synthesis of novel selective anaplastic lymphoma kinase inhibitors
Michellys, Pierre-Yves
Chen, Bei
Jiang, Tao
Jin, Yunho
Lu, Wenshuo
Marsilje, Thomas H.
Pei, Wei
Uno, Tetsuo
Zhu, Xuefeng
Wu, Baogen
Truc Ngoc Nguyen
Bursulaya, Badry
Lee, Christian
Li, Nanxin
Kim, Sungjoon
Tuntland, Tove
Liu, Bo
Sun, Frank
Steffy, Auzon
Hood, Tami
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (03) : 1090 - 1096
[4] Rapid Development of Piperidine Carboxamides as Potent and Selective Anaplastic Lymphoma Kinase Inhibitors
Bryan, Marian C.
Whittington, Douglas A.
Doherty, Elizabeth M.
Falsey, James R.
Cheng, Alan C.
Emkey, Renee
Brake, Rachael L.
Lewis, Richard T.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (04) : 1698 - 1705
[5] Discovery of potent and selective orally active inhibitors of anaplastic lymphoma kinase (ALK)
Shakespeare, William
Fantin, Valeria
Wang, Frank
Kohlmann, Anna
Liu, Shuangying
Huang, Wei-Sheng
Wang, Yihan
Zou, Dong
Thomas, Mathew
Li, Feng
Qi, Jiwei
Cai, Lisi
Dwight, Thimothy
Xu, Yongjin
Xu, Rongsong
Dodd, Rory
Xu, Qihong
Anjum, Rana
Zhang, Sen
Keats, Jeffrey
Xue, Ling
Wardwell, Scott
Ning, Yaoyu
Moran, Lauren
Mohemmad, Qurish
Zhu, Xiaotian
Narasimhan, Narayana
Rivera, Victor
Dalgarno, David
Clackson, Tim
CANCER RESEARCH, 2009, 69
[6] Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib
Huang, Qinhua
Johnson, Ted W.
Bailey, Simon
Brooun, Alexei
Bunker, Kevin D.
Burke, Benjamin J.
Collins, Michael R.
Cook, Andrew S.
Cui, J. Jean
Dack, Kevin N.
Deal, Judith G.
Deng, Ya-Li
Dinh, Dac
Engstrom, Lars D.
He, Mingying
Hoffman, Jacqui
Hoffman, Robert L.
Johnson, Patrick S.
Kania, Robert S.
Lam, Hieu
Lam, Justine L.
Le, Phuong T.
Li, Qiuhua
Lingardo, Laura
Liu, Wei
Lu, Melissa West
McTigue, Michele
Palmer, Cynthia L.
Richardson, Paul F.
Sach, Neal W.
Shen, Hong
Smeal, Tod
Smith, Graham L.
Stewart, Albert E.
Timofeevski, Sergei
Tsaparikos, Konstantinos
Wang, Hui
Zhu, Huichun
Zhu, Jinjiang
Zou, Helen Y.
Edwards, Martin P.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (04) : 1170 - 1187
[7] Identification and characterization of novel, potent, and selective inhibitors of protein kinase
Sharlow, Elizabeth R.
Wipf, Peter
Wang, Jane
Lazo, John S.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[8] Discovery and Optimization of a Novel Series of Potent Mutant B-RafV600E Selective Kinase Inhibitors
Vasbinder, Melissa M.
Aquila, Brian
Augustin, Martin
Chen, Huawei
Cheung, Tony
Cook, Donald
Drew, Lisa
Fauber, Benjamin P.
Glossop, Steve
Grondine, Michael
Hennessy, Edward
Johannes, Jeffrey
Lee, Stephen
Lyne, Paul
Moertl, Mario
Omer, Charles
Palakurthi, Sangeetha
Pontz, Timothy
Read, Jon
Sha, Li
Shen, Minhui
Steinbacher, Stefan
Wang, Haixia
Wu, Allan
Ye, Minwei
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (05) : 1996 - 2015
[9] Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase
Mologni, Luca
Tardy, Sebastien
Zambon, Alfonso
Orsato, Alexandre
Bisson, William H.
Ceccon, Monica
Viltadi, Michela
D'Attoma, Joseph
Pannilunghi, Sara
Vece, Vito
Bertho, Jerome
Goekjian, Peter
Scapozza, Leonardo
Gambacorti-Passerini, Carlo
ACS OMEGA, 2022, 7 (20): : 17083 - 17097
[10] Molecular characterization of WDCP, a novel fusion partner for the anaplastic lymphoma tyrosine kinase ALK
Yokoyama, Noriko
Miller, W. Todd
BIOMEDICAL REPORTS, 2015, 3 (01) : 9 - 13

← 1 2 3 4 5 →